A dissolvable oral dispersible film of dolutegravir could transform treatment ANALYSIS | MELODY CHIRONDA | In the fight ...

MIT engineers have developed a new drug delivery method that could change long-term treatments with fewer injections and less ...

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...

Winnie Byanyima, head of UNAIDS, criticized the impact of reduced U.S. funding in combatting HIV. She proposed a deal to U.S.

The future of HIV care requires balancing scientific advancement with practical implementation. Long-acting antiretroviral ...

Gilead Sciences has been one of the best-performing large biotech companies over the past year, rising about 50%. That is largely due to excitement over its [long-acting HIV prevention drug]( ...

The World Health Organization (WHO) has issued a grave warning about an imminent HIV drug shortage in several countries ...

Quebec is the first province to publicly cover costs of long-acting injectable HIV prevention medication Apretude. Experts say it's a much-needed, long-awaited tool — and they're pushing to make it ...

A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

The province passed legislation last year that banned supervised drug-use sites deemed too close to schools or daycares and ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...